Investigating the rapid diagnosis of gliomas from serum samples using infrared spectroscopy and cytokine and angiogenesis factors
- 7 July 2013
- journal article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 405 (23) , 7347-7355
Abstract
The ability to diagnose brain cancer rapidly from serum samples is of great interest; such a diagnosis would allow for rapid testing and time to results providing a responsive diagnostic environment, ability to monitor treatment efficacy, early detection of recurrent tumours and screening techniques. Current methods rely upon subjective, time-consuming tests such as histological grading and are particularly invasive with the diagnostic test requiring hospitalisation of 2–3 days. A rapid diagnostic method based upon serum samples would allow for a relatively non-invasive test and open up the possibility of screening for brain cancer. We report for the first time the use of a Bioplex immunoassay to provide cytokine and angiogenesis factor levels that differ between serum from glioma and non-cancer patients specifically angiopoietin, follistatin, HGF, IL-8, leptin, PDGF-BB and PECAM-1 providing sensitivities and specificities as high as 88 % and 81 %, respectively. We also report, for the first time, the use of serum ATR-FTIR combined with a RBF SVM for the diagnosis of gliomas from non-cancer patients with sensitivities and specificities as high as 87.5 % and 100 %, respectively. We describe the combination of these techniques in an orthogonal diagnostic regime, providing strength to the diagnosis through data combinations, in a rapid diagnostic test within 5 h from serum collection (10 min for ATR-FTIR and 4 h for the Bioplex Immunoassay). This regime has the ability to revolutionise the clinical environment by providing objective measures for diagnosis allowing for increased efficiency with corresponding decreases in mortality, morbidity and economic impact upon the health services. Figure ᅟKeywords
This publication has 38 references indexed in Scilit:
- Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancerBMC Cancer, 2011
- What we have learned from randomized trials of prostate cancer screeningAsian Journal of Andrology, 2011
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Profiling of cytokines and angiogenic factors (C/AF) in head and neck (HN) cancer correlates circulating biomarkers with clinical outcomes following induction chemotherapyJournal of Clinical Oncology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopyThe Analyst, 2006
- Molecular Diagnostics in Prostate CancerEAU Update Series, 2005
- Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomasBrain Research Reviews, 2004
- Screening for prostate cancerThe Lancet, 2003
- Intracellular carotenoid levels measured by Raman microspectroscopy: Comparison of lymphocytes from lung cancer patients and healthy individualsInternational Journal of Cancer, 1997